PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $490,551 | -66.3% | 47,488 | -57.2% | 0.00% | – |
| Q2 2023 | $1,455,040 | +207.9% | 110,987 | +162.6% | 0.00% | – |
| Q1 2023 | $472,534 | -14.7% | 42,266 | -35.6% | 0.00% | – |
| Q4 2022 | $553,648 | +150.5% | 65,676 | +337.5% | 0.00% | – |
| Q2 2022 | $221,000 | -94.8% | 15,011 | -91.2% | 0.00% | -100.0% |
| Q1 2022 | $4,227,000 | +153.0% | 170,353 | +227.0% | 0.00% | +100.0% |
| Q4 2021 | $1,671,000 | +623.4% | 52,100 | +711.8% | 0.00% | – |
| Q3 2021 | $231,000 | -91.8% | 6,418 | -90.0% | 0.00% | -100.0% |
| Q2 2021 | $2,824,000 | +782.5% | 64,000 | +813.9% | 0.00% | – |
| Q1 2021 | $320,000 | – | 7,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |